Pipeline

Lead candidates

Indication

Mode of therapy

Proof of concept

Preclinical studies

Phase 1/2a
clinical trial

Orphan Drug Designation

Cystic fibrosis

Add-on to standard of care

0%

Cystic fibrosis and other respiratory diseases

0%

Idiopathic pulmonary fibrosis

0%